nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antithrombotic therapy after mitral valve repair: VKA or aspirin?
|
Wall, Sake J. van der |
|
2018 |
46 |
4 |
p. 473-481 |
artikel |
2 |
A retrospective analysis of the periprocedural management of oral anticoagulants in patients undergoing interventional radiology procedures
|
Marsh, Kassandra |
|
2018 |
46 |
4 |
p. 451-460 |
artikel |
3 |
Assessment of patients post reversal with idarucizumab
|
Raco, Veronica |
|
2018 |
46 |
4 |
p. 466-472 |
artikel |
4 |
Balloon pulmonary angioplasty is a promising option in thalassemic patients with inoperable chronic thromboembolic pulmonary hypertension
|
Karyofyllis, Panagiotis |
|
2018 |
46 |
4 |
p. 516-520 |
artikel |
5 |
Bivalirudin for left ventricular assist device thrombosis
|
Weeks, Phillip |
|
2018 |
46 |
4 |
p. 496-501 |
artikel |
6 |
Characteristics, treatment patterns and outcomes of patients presenting with venous thromboembolic events after knee arthroscopy in the RIETE Registry
|
Weinberg, Ido |
|
2018 |
46 |
4 |
p. 551-558 |
artikel |
7 |
Comparison of rivaroxaban concentrations between Asians and Caucasians and their correlation with PT/INR
|
Ng Tsai, Hobart Owen |
|
2018 |
46 |
4 |
p. 541-548 |
artikel |
8 |
Correction to: Antithrombotic therapy after mitral valve repair: VKA or aspirin?
|
Wall, Sake J. van der |
|
2018 |
46 |
4 |
p. 482 |
artikel |
9 |
Drug interaction as a predictor of direct oral anticoagulant drug levels in atrial fibrillation patients
|
Hirsh Raccah, Bruria |
|
2018 |
46 |
4 |
p. 521-527 |
artikel |
10 |
Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry
|
Jackson, Larry R. |
|
2018 |
46 |
4 |
p. 435-439 |
artikel |
11 |
Effect of remote ischaemic conditioning on platelet aggregation and platelet turnover
|
Rise, Nina |
|
2018 |
46 |
4 |
p. 528-533 |
artikel |
12 |
Evaluation of direct oral anticoagulants for the treatment of venous thromboembolism in the oncology population
|
Hedvat, Jessica |
|
2018 |
46 |
4 |
p. 483-487 |
artikel |
13 |
Influence of cytochrome P450 polymorphisms on the antiplatelet effects of prasugrel in patients with non-cardioembolic stroke previously treated with clopidogrel
|
Kitazono, Takanari |
|
2018 |
46 |
4 |
p. 488-495 |
artikel |
14 |
Lights and shadows of long-term dual antiplatelet therapy in “real life” clinical scenarios
|
Scherillo, Marino |
|
2018 |
46 |
4 |
p. 559-569 |
artikel |
15 |
More valid and reliable thrombophilia testing is required for predicting the recurrence and the required duration of treatment for venous thromboembolism
|
Iltar, Utku |
|
2018 |
46 |
4 |
p. 571 |
artikel |
16 |
Pacemaker-associated thrombosis in ongoing therapy with edoxaban tosylate
|
Di Vincenzo, Angelo |
|
2018 |
46 |
4 |
p. 549-550 |
artikel |
17 |
Quality of direct oral anticoagulant therapy in elderly patients with non-valvular atrial fibrillation
|
Agirbasli, Mehmet |
|
2018 |
46 |
4 |
p. 570 |
artikel |
18 |
Reverse correlations of collagen-dependent platelet aggregation and adhesion with GPVI shedding during storage
|
Hosseini, Ehteramolsadat |
|
2018 |
46 |
4 |
p. 534-540 |
artikel |
19 |
Tenecteplase versus alteplase for management of acute ischemic stroke: a pairwise and network meta-analysis of randomized clinical trials
|
Kheiri, Babikir |
|
2018 |
46 |
4 |
p. 440-450 |
artikel |
20 |
The impact of co-morbidity on the disease burden of VTE
|
Kroep, Sonja |
|
2018 |
46 |
4 |
p. 507-515 |
artikel |
21 |
Utilization rates of enoxaparin and heparin in deep venous thrombosis prophylaxis after education and electronic order change at a single institution: a quality improvement study
|
Hoang, Linda |
|
2018 |
46 |
4 |
p. 502-506 |
artikel |
22 |
Warfarin control in patients transitioning to warfarin after non-vitamin K oral anticoagulant (NOAC) therapy
|
Bernaitis, Nijole |
|
2018 |
46 |
4 |
p. 461-465 |
artikel |